Avid Bioservices Inc (CDMO)

[geocappy1]

I think your prediction is pretty close to hat I said. They will become an early development company leading to partnerships and at some point may become a early development arm for a single company. This method will allow them to turn over late stage trials to others while maintaining their early development arm to keep the BP honest as they could offer data to other companies.

Down the road, if manufacturing revenue becomes significant to limit dilution and they are unhappy with how they are being treated by BP they can look again at later phase development when they have excess revenue.